Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Bladder Cancer |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk
Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast.
Adv Ther. 2024 Feb 2. doi: 10.1007/s12325-023-02763.
PubMed
Comparison of DNA methylation and cytology tests in urine to detect upper tract
urothelial carcinoma: A paired-design diagnostic study.
Am J Clin Pathol. 2024;161:115-121.
PubMed
Abstract available
Ann Noninvasive Electrocardiol
Electrocardiographic characteristics of bladder cancer patients receiving
preoperative chemotherapy combined with immunotherapy.
Ann Noninvasive Electrocardiol. 2024;29:e13107.
PubMed
Abstract available
p35/CDK5 Regulates Bladder Cancer Proliferation and Migration and Promotes Higher
Tumor Grade and Poor Survival Rate in Patients With Bladder Cancer.
Anticancer Res. 2024;44:543-553.
PubMed
Abstract available
Noninvasive Papillary Urothelial Carcinoma of the Bladder: An Institutional
Experience Focusing on Tumors With Borderline Features.
Arch Pathol Lab Med. 2024;148:223-229.
PubMed
Abstract available
Definition of the prognosis value of urine extracellular vesicles ZNF540 in
bladder cancer based on GEO database.
Asian J Surg. 2024 Jan 30:S1015-9584(24)00109.
PubMed
Prognostic significance of lncRNA AL354919.2 in bladder cancer.
Asian J Surg. 2024 Jan 25:S1015-9584(24)00099.
PubMed
Biochim Biophys Acta Mol Cell Res
Squalene monooxygenase facilitates bladder cancer development in part by
regulating PCNA.
Biochim Biophys Acta Mol Cell Res. 2024;1871:119681.
PubMed
Abstract available
Nanoreactor based on single-atom nanoenzymes promotes ferroptosis for cancer
immunotherapy.
Biomater Adv. 2024;157:213758.
PubMed
Abstract available
Microchip for detection of cell-free DNA in urine to help identify patients with
bladder cancer.
BJU Int. 2024 Jan 30. doi: 10.1111/bju.16271.
PubMed
Feasibility and safety of laparoscopic radical cystectomy for male octogenarians
with muscle-invasive bladder cancer.
BMC Cancer. 2024;24:159.
PubMed
Abstract available
Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a
qualitative study exploring patient priorities and counselling needs when making
a treatment choice.
BMC Cancer. 2024;24:160.
PubMed
Abstract available
Application of contrast-enhanced ultrasound in diagnosis and grading of bladder
urothelial carcinoma.
BMC Med Imaging. 2024;24:26.
PubMed
Abstract available
Is switching intravesical chemotherapeutic agents beneficial in short-term
recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective
study.
BMC Urol. 2024;24:25.
PubMed
Abstract available
A risk model based on lncRNA-miRNA-mRNA gene signature for predicting prognosis
of patients with bladder cancer.
Cancer Biomark. 2024 Jan 8. doi: 10.3233/CBM-230216.
PubMed
Abstract available
Construction and identification of lncRNA/circRNA-coregulated ceRNA networks in
gemcitabine-resistant bladder carcinoma.
Carcinogenesis. 2023;44:847-858.
PubMed
Abstract available
Cell Mol Biol (Noisy-le-grand)
The relationship between the expression of lncRNA MALAT1 and clinical features
and prognosis in bladder cancer: A meta-analysis.
Cell Mol Biol (Noisy-le-grand). 2023;69:166-171.
PubMed
Abstract available
PRPF19 functions in DNA damage repair and gemcitabine sensitivity via regulating
DDB1 in bladder cancer cells.
Cytotechnology. 2024;76:85-96.
PubMed
Abstract available
Single-cell transcriptome analysis reveals the association between histone
lactylation and cisplatin resistance in bladder cancer.
Drug Resist Updat. 2024;73:101059.
PubMed
Abstract available
Retracted: Preoperative Nutritional Risk Assessment for Predicting Complications
after Radical Cystectomy plus Urinary Diversion for Bladder Cancer.
Emerg Med Int. 2024;2024:9849523.
PubMed
Abstract available
PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in
bladder cancer.
Environ Toxicol. 2024 Jan 31. doi: 10.1002/tox.24153.
PubMed
Abstract available
Eur Heart J Cardiovasc Imaging
Cardiac metastasis from urothelial carcinoma: a stealthy precursor.
Eur Heart J Cardiovasc Imaging. 2024;25:e92.
PubMed
Circulating Tumour Dna Detection By The Urine-Informed Analysis Of Archival Serum
Samples From Muscle-Invasive Bladder Cancer Patients.
Eur Urol. 2024 Jan 31:S0302-2838(24)00017-4. doi: 10.1016/j.eururo.2024.
PubMed
Reply to Marco Moschini, Francesco Montorsi, Andrea Salonia, Giorgio Gandaglia
and Alberto Briganti's Letter to the Editor Re: Francesco Soria, Matteo Rosazza,
Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus
Calmette-Guerin (BCG)
Eur Urol Focus. 2024 Jan 25:S2405-4569(24)00004.
PubMed
Re: Christopher D. Gaffney, Andrew Katims, Neeta D'Souza, Marc A. Bjurlin,
Richard S. Matulewicz. Bladder Cancer Carcinogens: Opportunities for Risk
Reduction. Eur Urol Focus 2023;9:575-8.
Eur Urol Focus. 2024 Jan 25:S2405-4569(24)00006.
PubMed
Achieving Benchmarks for National Quality Indicators Reduces Recurrence and
Progression in Non-muscle-invasive Bladder Cancer.
Eur Urol Oncol. 2024 Jan 30:S2588-9311(24)00037.
PubMed
Abstract available
Association of Age with Non-muscle-invasive Bladder Cancer: Unearthing a
Biological Basis for Epidemiological Disparities?
Eur Urol Oncol. 2024 Jan 31:S2588-9311(24)00036.
PubMed
Abstract available
Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine
Sample.
Eur Urol Open Sci. 2023;59:18-26.
PubMed
Abstract available
Prognostic biomarker DARS2 correlated with immune infiltrates in bladder tumor.
Front Immunol. 2024;14:1301945.
PubMed
Abstract available
Integration of multi-omics and clinical treatment data reveals bladder cancer
therapeutic vulnerability gene combinations and prognostic risks.
Front Immunol. 2024;14:1301157.
PubMed
Abstract available
Type 2 innate lymphoid cells are not involved in mouse bladder tumor development.
Front Immunol. 2024;14:1335326.
PubMed
Abstract available
Depletion of the m1A writer TRMT6/TRMT61A reduces proliferation and resistance
against cellular stress in bladder cancer.
Front Oncol. 2024;13:1334112.
PubMed
Abstract available
Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis,
and outcomes.
Front Pharmacol. 2024;14:1326627.
PubMed
Abstract available
Development and validation of a CT-based deep learning radiomics nomogram to
predict muscle invasion in bladder cancer.
Heliyon. 2024;10:e24878.
PubMed
Abstract available
Plasma-Activated Media Produced by a Microwave-Excited Atmospheric Pressure
Plasma Jet Is Effective against Cisplatin-Resistant Human Bladder Cancer Cells In
Vitro.
Int J Mol Sci. 2024;25:1249.
PubMed
Abstract available
Combinatorial Gene Expression Profiling of Serum HULC, HOTAIR, and UCA1 lncRNAs
to Differentiate Hepatocellular Carcinoma from Liver Diseases: A Systematic
Review and Meta-Analysis.
Int J Mol Sci. 2024;25:1258.
PubMed
Abstract available
An iodine?labelled Antibody-drug conjugate PET probe for noninvasive monitoring
of Nectin-4 expression in urothelial carcinoma.
Int J Pharm. 2024;651:123756.
PubMed
Abstract available
Reactive arthritis as a rare complication of intravesical bacillus
Calmette-Guerin treatment: Report of two cases.
Int J Rheum Dis. 2024;27:e14862.
PubMed
Abstract available
circCD2AP promotes epithelial mesenchymal transition and stemness in bladder
cancer by regulating FOXQ1/USP21 axis.
iScience. 2023;27:108447.
PubMed
Abstract available
A prospective evaluation of quality of life, psychosocial distress, and
functional outcomes two years after radical cystectomy and urinary diversion in
842 German bladder cancer patients.
J Cancer Surviv. 2024 Jan 30. doi: 10.1007/s11764-024-01535.
PubMed
Abstract available
Quantitative image analysis of intracellular protein translocation in
3-dimensional tissues for pharmacodynamic studies of immunogenic cell death.
J Control Release. 2024;365:89-100.
PubMed
Abstract available
Evaluation of a New Cystoscopic Cryocatheter and Method for the In Situ
Destruction of Bladder Cancer: Preliminary In vivo Study.
J Endourol. 2024 Jan 27. doi: 10.1089/end.2023.0635.
PubMed
Abstract available
Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of
bladder cancer.
J Extracell Vesicles. 2024;13:e12402.
PubMed
Abstract available
Exploration of the prognostic effect of costimulatory genes in bladder cancer.
J Gene Med. 2024;26:e3655.
PubMed
Abstract available
Unveiling Anoikis-related genes: A breakthrough in the prognosis of bladder
cancer.
J Gene Med. 2024;26:e3651.
PubMed
Abstract available
MicroRNA-299-3p inhibits cell proliferation, motility, invasion and angiogenesis
via VEGFA in upper tract urothelial carcinoma.
J Gene Med. 2024;26:e3616.
PubMed
Abstract available
The clinical validity of urinary pellet DNA monitoring for the diagnosis of
recurrent bladder cancer.
J Mol Diagn. 2024 Jan 30:S1525-1578(24)00012.
PubMed
Abstract available
Clearing the Smoke: Underreporting of Smoking Status in Food and Drug
Administration-Approved Bladder Cancer Therapeutic Trials.
J Urol. 2024 Feb 1:101097JU0000000000003853. doi: 10.1097/JU.0000000000003853.
PubMed
Latin American Consensus for the Evaluation and Treatment of Patients With
Metastatic/Locally Advanced Urothelial Carcinoma.
JCO Glob Oncol. 2024;10:e2300244.
PubMed
Abstract available
Prostate Cancer among Patients Undergoing Radical Cystoprostatectomy for Bladder
Cancer in the Department of Urology in a Tertiary Care Centre.
JNMA J Nepal Med Assoc. 2023;61:782-786.
PubMed
Abstract available
[RBMX overexpression inhibits proliferation, migration, invasion and glycolysis
of human bladder cancer cells by downregulating PKM2].
Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:9-16.
PubMed
Abstract available
Combination neoadjuvant therapies are paving the way for bladder preservation to
become the standard for selected patients.
Nat Rev Clin Oncol. 2024;21:87-88.
PubMed
Management of patients with muscle-invasive bladder cancer with clinical evidence
of pelvic lymph node metastases.
Nat Rev Urol. 2024 Jan 31. doi: 10.1038/s41585-023-00842.
PubMed
Abstract available
Nucleosides Nucleotides Nucleic Acids
Genetic insights into bladder cancer: the impact of SIRT1 gene polymorphism.
Nucleosides Nucleotides Nucleic Acids. 2024.
PubMed
Abstract available
A novel predict method for muscular invasion of bladder cancer based on 3D mp-MRI
feature fusion.
Phys Med Biol. 2024 Feb 2. doi: 10.1088/1361-6560.
PubMed
Abstract available
Proliferation and immunohistochemistry for p53, CD25 and CK20 in predicting
prognosis of non-muscle invasive papillary urothelial carcinomas.
PLoS One. 2024;19:e0297141.
PubMed
Abstract available
Author Correction: Duality of the SVIL expression in bladder cancer and its
correlation with immune infiltration.
Sci Rep. 2024;14:2369.
PubMed
Proton pump inhibitors and potassium competitive acid blockers decrease
pembrolizumab efficacy in patients with metastatic urothelial carcinoma.
Sci Rep. 2024;14:2520.
PubMed
Abstract available
Artificial intelligence assisted patient blood and urine droplet pattern analysis
for non-invasive and accurate diagnosis of bladder cancer.
Sci Rep. 2024;14:2488.
PubMed
Abstract available
Identification and preliminary analysis of hub genes associated with bladder
cancer progression by comprehensive bioinformatics analysis.
Sci Rep. 2024;14:2782.
PubMed
Abstract available
Integrated bioinformatics analysis identifies a Ferroptosis-related gene
signature as prognosis model and potential therapeutic target of bladder cancer.
Toxicol Res (Camb). 2024;13:tfae010.
PubMed
Abstract available
Time to progression is the main predictor of survival in patients with high-risk
nonmuscle invasive bladder cancer: Results from a machine learning-based analysis
of a large multi-institutional database.
Urol Oncol. 2024 Jan 31:S1078-1439(24)00003.
PubMed
Abstract available
Standardization of the evaluation and surveillance of patients with BCG
unresponsive high grade non-muscle invasive bladder cancer clinical trials.
Urol Oncol. 2024 Feb 1:S1078-1439(24)00020-6. doi: 10.1016/j.urolonc.2024.
PubMed
Abstract available
Relationship Between Availability of Urologists and Primary Care Providers and
Stage of Diagnosis for Invasive Urinary Bladder Cancer.
Urol Pract. 2024 Jan 15:101097UPJ0000000000000503.
PubMed
Abstract available
Malignancy in the public life: the story of Hubert Humphrey's bladder cancer.
Urology. 2024 Jan 31:S0090-4295(24)00017-7. doi: 10.1016/j.urology.2023.
PubMed
[Mesonephric-like adenocarcinoma of the female urinary bladder associated with
endometriosis: report of a case].
Zhonghua Bing Li Xue Za Zhi. 2024;53:201-203.
PubMed
Thank you for your interest in scientific medicine.